e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical aspects of PAH and associated PH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The utility of brain natriuretic peptide in patients with stable chronic lung diseases
Y. Kida, H. Tomioka, R. Sekiya, S. Yamashita, T. Kaneda, C. Nishio, M. Kaneko, H. Fujii, K. Ishihara (Kobe, Japan)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Session:
Pulmonary circulation: clinical aspects of PAH and associated PH
Session type:
Thematic Poster Session
Number:
928
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kida, H. Tomioka, R. Sekiya, S. Yamashita, T. Kaneda, C. Nishio, M. Kaneko, H. Fujii, K. Ishihara (Kobe, Japan). The utility of brain natriuretic peptide in patients with stable chronic lung diseases. Eur Respir J 2012; 40: Suppl. 56, 928
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Elevated brain natriuretic peptide predicts mortality in interstitial lung disease
Source: Eur Respir J 2010; 36: 819-825
Year: 2010
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases
Source: Eur Respir J 2004; 24: Suppl. 48, 279s
Year: 2004
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007
Diffusing lung capacity and pro-brain natriuretic peptide in patients with limited cutaneous form of systemic sclerosis at risk for pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Does brain natriuretic peptide (BNP) at baseline influence the effects of nintedanib plus sildenafil in patients with IPF?
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Remarkable induction of brain natriuretic peptide in pulmonary emphysema after acute respiratory infection
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006
Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept